I would like to introduce you to a new biotechnology Startup community I’ve started with some colleagues: BiotechStart.org.

BiotechStart was created in the fall of 2011 to encourage the discussion of new startup models for the biotech world and to disseminate startup-centric information. Our thesis is that the biotech community lags other industries (tech, clean-tech, etc.) in its startup culture and believe it is missing a cohesive resource for learning and discussing about startup methods. We aim to connect entrepreneurs, potential entrepreneurs, mentors, mentees and everyone active in the biotech community.

Please check out BiotechStart and sign up (here). Myself and other like-minded folks are using it as a platform to discuss biotech startup ideas and are posting a lot of great content (BiotechStart RSS feed). I am aiming to still post and cross-post on Persistent Change, but you should also see all the great content on BiotechStart.

Cheers!

 

{ 1 comment }

  • Quit being a wimp about the state of Live Science Venture Capital (link)
  • Corporate VCs fill the growing life science VC gap (link)
  • VCs should first be Start-up CEO’s (link)
  • Will a VC bring in a pro-CEO once the round is closed? (link)

{ 1 comment }

PhD to Business – Lessons Learned

November 11, 2011

This post was originally posted on the Nature Biotech Trade Secrets blog.  The folks at Nature Biotech asked us authors for a description of how we’ve navigated our careers from bench to business.  My story is still a work in progress, but as a recent Ph.D. I do have some lessons learned of things you can do to prepare [...]

Read the full article →

Required Reading – Rusnano, Breakout Labs, VC, Burrill Report, etc.

October 30, 2011

Nanotech firms BIND and Selecta raise funds from Rusnano (here) Peter Thiel founds Biotech incubator Breakout labs (here) The ongoing plight of the VC industry (here) Podcast of Brad Feld of Foundry Group (here) The November 2011 Burrill Report (here)

Read the full article →

Share the Risk not the Channel and Sell, Sell, Sell

October 23, 2011

Traditionally, companies that supply equipment to scientific researchers have used direct sales to drive adoption and growth. For start-ups this would typically require a partnership with an established entity. But recently a new strategy has emerged where the web is used both to create buzz about a product, and as a channel to convert interest [...]

Read the full article →

Required Reading – Industrial Biology, DNAnexus, VC Barbells, etc.

October 19, 2011

California’s industrial biotechnology sector sees rapid growth (here) Google invests in DNAnexus for cloud based sequence data (here) The increasingly barbell nature of the VC industry (here) Corning’s surprisingly awesome video about glass (here)

Read the full article →

Is There Value in Debt for Early-Stage Technology Ventures?

October 13, 2011

Consider this scenario. You are an entrepreneur with an early-stage venture. Emerging from stealth mode, you make it your mission to speak to as many of the great and the good in the community to lay the groundwork for a future Series A financing. (Un)expectedly, someone immediately recognizes that after implementation of your technology – [...]

Read the full article →

Rough Few Months for DNA Sequencing Companies

October 11, 2011

It’s been a pretty rough ride for many of the life science tools companies, particularly for those involved in DNA sequencing. Illumina recently saw its share price tumble as sales plummeted in the third quarter (Reuters article). Illumina stated that the drop in sales was primarily due to uncertainty in the future levels of US and [...]

Read the full article →

Required Reading – FDA, Corporate VC, Getting Rich, Steve Jobs

October 6, 2011

The FDA (finally) incorporating innovation into their policy (here) Debunking corporate venture capital in biotech (here) The most patriotic thing you can do (here) Steve Jobs: How to live before you die (here)

Read the full article →

WSGR Fall 2011 Life Science Report

October 3, 2011

Wilson Sonsini Goodrich & Rosati (WSGR) recently released their semi-annual report on the Life Sciences (here).  Although a bit of an advert, the report is a worthwhile read with interesting insight and analysis on the industry.  Three articles in the report are particularly interesting: 1) Analysis of the recently legislated US Patent Reform, the “America [...]

Read the full article →